
How to improve access to cancer medicines in low and middle-income countries
Poor healthcare systems are a major barrier to patients accessing life-saving cancer medicines. Public-private partnerships could ensure better access.
A membership organization founded in 1933 and based in Geneva, the Union for International Cancer Control's (UICC) growing membership of over 1,000 organizations across 162 countries features the world's major cancer societies, ministries of health, research institutes and patient groups. Together with its members, key partners, the World Health Organization, the International Agency for Research on Cancer and others, UICC is tackling the growing cancer crisis on a global scale.
Poor healthcare systems are a major barrier to patients accessing life-saving cancer medicines. Public-private partnerships could ensure better access.
Remarkable progress has been made against cancer, and this must be sustained despite the disruption wrought by the COVID-19 pandemic. Here's how.

